The immunosuppressive drugs taken by kidney transplant recipients to prevent rejection all carry the same risk of developing cancer, according to a new study appearing in the May Journal of the American Society of Nephrology. The results suggest that no single immunosuppressive medication is to blame for the higher incidence of cancer seen among patients [Sign in to read the full article...]